• 临床研究 • 上一篇    下一篇

高出血风险MODS患者连续性血液滤过治疗抗凝方案的安全性及有效性分析

田惠玉,李建科,宋邵华,张杰,金玉洁,陆鹏,杨秀芬   

  1. 河北医科大学第一医院
  • 收稿日期:2013-12-05 修回日期:2014-02-08 出版日期:2014-06-15 发布日期:2014-06-15
  • 通讯作者: 金玉洁

Safety and Efficiency of Anticoagulation Methods during CVVH in the Patients with MODS with High-Risk Bleeding

  • Received:2013-12-05 Revised:2014-02-08 Published:2014-06-15 Online:2014-06-15

摘要: 目的 探讨高出血风险MODS患者连续性血液滤过(CVVH)抗凝方案的安全性及有效性分析。方法 选择我科高出血风险MODS行连续性血液滤过治疗的患者40例,分为无肝素抗凝组(A组)和小剂量肝素抗凝组(B组),观察两组患者治疗前、治疗后24h、48h ApacheⅡ评分、血小板计数、凝血功能、尿素氮、肌酐、PaO2/FIO2的变化,并记录两组患者滤器寿命、机械通气时间、住ICU时间及出血并发症的发生情况。结果 1. 小剂量肝素抗凝组患者治疗后24h、48h血肌酐、 PaO2/FIO2、ApacheⅡ评分及尿素氮水平均较无肝素抗凝组明显好转,差异有统计学意义(P<0.05)。2. 小剂量肝素抗凝组患者治疗后24h APTT、TT均较治疗前明显延长,血小板计数明显下降,但随着治疗时间的延长,APTT、TT及血小板计数无明显变化。3. B组患者的平均机械通气时间、住ICU时间均较A组患者明显缩短,滤器使用寿命较A组明显延长,差异有统计学意义(P<0.05)。4. B组患者发现1例皮肤黏膜出血现象,无严重出血并发症发生。结论 单中心研究显示高出血风险MODS患者采用小剂量肝素抗凝可以保证CVVH治疗的顺利进行,临床应用安全、有效。

关键词: 多脏器功能不全综合征, 连续性静脉静脉血液滤过, 高出血风险, 凝血功能, 有效性, 安全性

Abstract: [Abstract] Objective To investigate safety and efficiency of anti- coagulation methods in the patients with high-risk bleeding multiple organ dysfunction syndrome (MODS) during continuous veno-venous hemofiltration(CVVH). Methods Forty patients with high-risk bleeding MODS during CVVH in our hospital were divided into heparin-free group(A group) and low-dose heparin group(B group). The changes of blood coagulation function, the counts of platelets, blood urea nitrogen, serum creatinine, PaO2/FIO2 and Apache Ⅱscores in two groups before treatment, at 24h,48h after treatment were measured. Filter lifespan, median ventilation time, ICU admission time and bleeding complications were observed. Results 1. There was significant difference between the levels of blood urea nitrogen, serum creatinine, PaO2/FIO2 and Apache Ⅱscores at 24h,48h after treatment in low-dose heparin group and that in heparin-free group (P<0.05).2. The levels of APTT, TT were prolonged,the counts of PLT were significantly lower at 24h after treatment than that before treatment in low-dose heparin group, the levels of APTT, TT, the counts of PLT had no changes comparing prolonged time of CVVH therapy. 3. Average ventilation time, ICU admission time were obviously shorter in low-dose heparin group than that in heparin-free group, Filter lifespan was longer in low-dose heparin group than that in heparin-free group, there was significant difference (P<0.05). 4. Bleeding in skin and mucosa was observed in 1 case in low-dose heparin group, there was no other severe bleeding complications. Conclusion The results of monocentic study show that low dose of heparin ensure smooth operation of CVVH in the Patients with MODS with high-risk bleeding, clinical application is safe, efficient.

Key words: Multiple organ dysfunction syndrome, Continuous Veno- Venous Hemofiltration, High-risk bleeding, coagulation function, Efficiency, Safety